Search research articles
Contact Us
Filters
Showing results (1-10 of 45) with videos related to
Page
of 5
Sort By:
Bioanalysis
|
April 1, 2015
A historical perspective on radioisotopic tracers in metabolism and biochemistry
Graham Lappin
Clinical Pharmacology in Drug Development
|
May 4, 2016
The expanding utility of microdosing
Graham Lappin
Journal of Clinical Pharmacology
|
June 16, 2015
Approaches to intravenous clinical pharmacokinetics: Recent developments with isotopic microtracers
Graham Lappin
Biologist (London, England)
|
February 20, 2002
Chemical toxins and body defences
Graham Lappin
Bioanalysis
|
November 19, 2010
Microdosing: current and the future
Graham Lappin
Expert Opinion on Drug Metabolism & Toxicology
|
August 6, 2008
Biomedical accelerator mass spectrometry: recent applications in metabolism and pharmacokinetics
Graham Lappin, Lloyd Stevens
Bioanalysis
|
November 19, 2010
Addressing metabolite safety during first-in-man studies using ¹⁴C-labeled drug and accelerator mass spectrometry
Graham Lappin, Mark Seymour
Analytical and Bioanalytical Chemistry
|
November 19, 2003
Current perspectives of 14C-isotope measurement in biomedical accelerator mass spectrometry
Graham Lappin, R Colin Garner
Expert Opinion on Drug Metabolism & Toxicology
|
August 23, 2006
The use of accelerator mass spectrometry to obtain early human ADME/PK data
Graham Lappin, R Colin Garner
Expert Opinion on Drug Metabolism & Toxicology
|
December 2, 2008
The utility of microdosing over the past 5 years
Graham Lappin, R Colin Garner
Page
of 5
Search research articles
Search
Showing results (1-10 of 45) with videos related to
Sort By:
Page
of 5
Bioanalysis
|
April 1, 2015
A historical perspective on radioisotopic tracers in metabolism and biochemistry
Graham Lappin
Clinical Pharmacology in Drug Development
|
May 4, 2016
The expanding utility of microdosing
Graham Lappin
Journal of Clinical Pharmacology
|
June 16, 2015
Approaches to intravenous clinical pharmacokinetics: Recent developments with isotopic microtracers
Graham Lappin
Biologist (London, England)
|
February 20, 2002
Chemical toxins and body defences
Graham Lappin
Bioanalysis
|
November 19, 2010
Microdosing: current and the future
Graham Lappin
Expert Opinion on Drug Metabolism & Toxicology
|
August 6, 2008
Biomedical accelerator mass spectrometry: recent applications in metabolism and pharmacokinetics
Graham Lappin, Lloyd Stevens
Bioanalysis
|
November 19, 2010
Addressing metabolite safety during first-in-man studies using ¹⁴C-labeled drug and accelerator mass spectrometry
Graham Lappin, Mark Seymour
Analytical and Bioanalytical Chemistry
|
November 19, 2003
Current perspectives of 14C-isotope measurement in biomedical accelerator mass spectrometry
Graham Lappin, R Colin Garner
Expert Opinion on Drug Metabolism & Toxicology
|
August 23, 2006
The use of accelerator mass spectrometry to obtain early human ADME/PK data
Graham Lappin, R Colin Garner
Expert Opinion on Drug Metabolism & Toxicology
|
December 2, 2008
The utility of microdosing over the past 5 years
Graham Lappin, R Colin Garner
Page
of 5